FDMT vs AMGN: Which Stock is Better?

Side-by-side comparison of 4D Molecular Therapeutics Inc and Amgen Inc in 2026

Comparison Updated:

FDMT

4D Molecular Therapeutics Inc

$8.46

AMGN

Amgen Inc

$377.00

Key Metrics Comparison

MetricFDMTAMGNWinner
Market Cap$533.07M$207.92BAMGN
P/E RatioN/A27.10AMGN
EPS (TTM)$N/A$14.23AMGN
Revenue Growth29.0%0.1%FDMT
Gross Margin-148295.8%70.8%AMGN

Analyze FDMT

Full quant analysis

Analyze AMGN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is FDMT or AMGN a better investment?

Comparing FDMT and AMGN: 4D Molecular Therapeutics Inc has a market cap of $533.07M while Amgen Inc has $207.92B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between FDMT and AMGN?

FDMT (4D Molecular Therapeutics Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: FDMT or AMGN?

Based on P/E ratios, compare detailed valuation metrics on our dashboard.

Which is growing faster: FDMT or AMGN?

FDMT has higher revenue growth at 29.0% vs 0.1% for AMGN.

Which company is more profitable: FDMT or AMGN?

Amgen Inc (AMGN) has higher gross margins at 70.8% compared to -148295.8% for FDMT.

Which is the larger company: FDMT or AMGN?

Amgen Inc (AMGN) is larger with a market cap of $207.92B compared to $533.07M for FDMT.

Should I buy FDMT or AMGN in 2026?

Both FDMT and AMGN have investment merit. FDMT trades at $8.46 while AMGN trades at $377.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between FDMT and AMGN stock?

Key differences: Market Cap ($533.07M vs $207.92B), P/E Ratio (N/A vs 27.1x), Revenue Growth (29.0% vs 0.1%), Gross Margin (-148295.8% vs 70.8%).

Popular Stock Comparisons